oxaliplatin+capecitabine

DRUG3 trials

Sponsors

Dutch Colorectal Cancer Group, Sun Yat-sen University, Peking Union Medical College Hospital

Conditions

Colon CancerColorectal CancerGastric or Gastroesophageal Junction AdenocarcinomaLiver Metastases

Phase 2

Efficacy and Safety of AK112 Combined Chemotherapy as Neoadjuvant Treatment for Signet Ring Cell-containing G/GEJ Adenocarcinoma

Not yet recruitingNCT07091227

Peking Union Medical College HospitalGastric or Gastroesophageal Junction Adenocarcinoma

Start: 2025-07-20End: 2029-07-20Target: 66Updated: 2025-07-29

Phase 3

Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer

TerminatedNCT00394992

Dutch Colorectal Cancer GroupColorectal Cancer, Liver Metastases

Start: 2006-12-31End: 2013-08-31Updated: 2014-02-04

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer

TerminatedNCT03970694

Sun Yat-sen UniversityColon Cancer

Start: 2019-05-11End: 2022-06-05Updated: 2022-06-08

Related Papers

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomised, controlled, phase 3 trial.

2024-09-216 citations

A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.

2010-10-1118 citations